Development of a two-stage crosslinking bio-ink for printing 3D tumor models

The intern will further improve the company’s proprietary biomaterials to create tumor models using cancer cells. These tumor models can be used as an alternative to traditional 2D cell culture and potentially animal testing for cancer drugs. These cancer models will cost a fraction of the cost of animal models and can be tested using existing pharmaceutical techniques and equipment. The intern will develop chemical approaches to modify the existing biomaterials to enable easy printing of tumor models. This research will allow the company to commercialize their biomaterials in the pharmaceuticals industry using the processes created in the project. The biomaterials and reagents used in in-vitro cancer drug screening are a $3.5 Billion market, and this research will help the company gain market share in the industry.

Faculty Supervisor:

Shirley Tang

Student:

Partner:

9215581 Canada Inc;University of Waterloo

Discipline:

Life Sciences

Sector:

Manufacturing

University:

University of Waterloo

Program: